What Happens When You Join a Clinical Trial: A Complete Timeline
Published April 6, 2026 · ClinicalTrials.gov data
Joining a clinical trial can feel overwhelming when you do not know what to expect. With 7,801 trials currently recruiting across 2540 conditions, more people are considering participation than ever. This guide walks you through every step — from your first inquiry to the end of the study.
Important: This is educational information, not medical advice. Talk to your doctor about whether a clinical trial is right for you.
Your Clinical Trial Timeline
Every trial is different, but most follow the same general sequence. Here is what to expect at each stage:
Discovery & First Inquiry
Timeline: Days to weeks
You find a trial through your doctor, a search tool like TrialFinder, or ClinicalTrials.gov. You contact the research site or your doctor refers you. The research coordinator does an initial phone screen to check basic eligibility — things like your diagnosis, age, and current treatments. This conversation usually takes 15-30 minutes.
Screening
Timeline: 1-4 weeks
If you pass the initial phone screen, you visit the research site for formal screening. This typically includes a physical examination, blood work, imaging scans (CT, MRI, or X-ray depending on the condition), and a detailed review of your medical history. The trial has specific eligibility criteria — screening determines whether you meet them. Some screenings are completed in a single visit; others require multiple appointments over several weeks.
Informed Consent
Timeline: 1-2 visits
Before joining, the research team walks you through the informed consent document. This explains everything: what the trial is testing, what treatment you may receive, potential risks and benefits, your schedule of visits, what costs the trial covers, and your right to leave at any time. Take your time with this step. You can bring the document home, discuss it with family, and ask as many questions as you need. Signing does not commit you permanently — you can still withdraw later.
Randomization & Baseline
Timeline: 1 visit
In randomized trials, a computer assigns you to a treatment group. This is not a choice made by your doctor or the sponsor — it is random by design to ensure fair results. You may be assigned to the experimental treatment group or the control group (which receives standard care or, less commonly, a placebo). Baseline measurements are taken so researchers can measure changes over time.
Treatment Period
Timeline: Weeks to years (varies by trial)
This is the core of the trial. You receive the assigned treatment and attend regular study visits. Visit frequency varies — some trials require weekly visits, others monthly. At each visit, the research team monitors your health, checks for side effects, and collects data. You may also need to keep a diary of symptoms or take medications on a schedule. If you experience concerning side effects at any point, tell your research team immediately.
Follow-Up
Timeline: Months to years after treatment ends
After the treatment period ends, follow-up visits continue. These check for lasting effects — both positive and negative. Follow-up visits are usually less frequent than treatment visits (quarterly or annually). The research team monitors your health and gathers long-term outcome data that is essential for understanding the full picture of the treatment.
End of Study
Timeline: Final visit
When the trial concludes, the research team discusses your results and next steps. If the treatment was beneficial, you may have options: some trials offer extension studies where you can continue receiving the treatment, and some sponsors provide compassionate use access while awaiting FDA approval. Your research team will help you transition back to standard care with your regular doctor.
What Protects You During a Trial
Clinical trials operate under strict oversight. An Institutional Review Board (IRB) reviews and approves every trial before it begins and monitors it throughout. A Data Safety Monitoring Board (DSMB) independently watches for safety signals during the trial — if the treatment is causing harm, the DSMB can halt the trial immediately. These protections exist at every stage of the timeline above.
How Long the Whole Process Takes
From first inquiry to end of active treatment, here is a rough breakdown for a typical Phase 3 trial:
- Discovery to screening: 1-4 weeks
- Screening to enrollment: 2-6 weeks
- Treatment period: 6 months to 3+ years
- Follow-up after treatment: 6 months to 2+ years
Your research coordinator will give you a specific expected timeline during informed consent. Ask about it — knowing the commitment upfront helps you plan.
Frequently Asked Questions
How long does a clinical trial last from start to finish?
It varies widely by phase and condition. Phase 1 trials may last a few months. Phase 2 trials typically run 1-2 years. Phase 3 trials can take 2-4 years. Your active participation (treatment plus follow-up) is usually a subset of the total trial duration — your research team will give you a specific timeline during informed consent.
What happens during the screening process?
Screening confirms whether you meet the trial's eligibility criteria. It typically includes a physical exam, blood tests, imaging scans, and a review of your medical history. Screening can take a single visit or several weeks depending on the trial. You will not receive any experimental treatment during screening.
Can I continue seeing my regular doctor during a clinical trial?
Yes. Your regular doctor remains your primary care provider throughout the trial. The research team focuses on the trial-related treatment and monitoring, while your regular doctor continues managing your overall health. The two teams often communicate to coordinate your care.
What happens after the clinical trial ends?
After the treatment period, there is usually a follow-up phase where researchers monitor you for lasting effects. If the treatment was effective, some trials offer continued access through extension studies or compassionate use programs. Your research team will discuss transition plans with you before the trial concludes.
About This Data
Trial information sourced from ClinicalTrials.gov API v2. We track 7,801 recruiting trials across 2540 conditions. This is educational information — talk to your doctor about clinical trials. See our methodology.